Bristol-Myers Competitors

Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Bristol-Myers Squibb's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Bristol-Myers Squibb in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
1,2821,2871,292
Details
Intrinsic
Valuation
LowReal ValueHigh
1,0811,0861,416
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Bristol-Myers Squibb. Your research has to be compared to or analyzed against Bristol-Myers Squibb's peers to derive any actionable benefits. When done correctly, Bristol-Myers Squibb's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Bristol-Myers Squibb.

Bristol-Myers Squibb Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Bristol-Myers Squibb and its competitors represents the degree of relationship between the price movements of corresponding otcs. A correlation of about +1.0 implies that the price of Bristol-Myers and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Bristol-Myers Squibb does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Bristol-Myers Squibb Competition Risk-Adjusted Indicators

Nowadays, there is a big difference between Bristol-Myers OTC Pink Sheet performing well and Bristol-Myers Squibb company doing well compared to the competition. There are way too many exceptions to the normal that investors can tell for sure what's good or bad unless they analyze Bristol-Myers Squibb's multiple risk-adjusted performance indicators. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean
Deviation
Jensen
Alpha
Sortino
Ratio
Treynor
Ratio
Semi
Deviation
Information
Ratio
Expected
Shortfall
Potential
Upside
Value
At Risk
Maximum
Drawdown
ARGD 0.88 (0.05)  0.00 (0.06)  0.00 (0.09)  0.00  2.14 (1.75)  7.31 
BHFAL 1.16 (0.03) (0.04)  0.04  1.64 (0.0439) (1.23)  2.99 (3.11)  8.04 
CNFRL 0.63 (0.05)  0.00 (0.50)  0.00 (0.14)  0.00  1.74 (2.12)  6.18 
JSM 1.69 (0.26)  0.00 (0.29)  0.00 (0.12)  0.00  4.19 (4.37)  12.54 
LTSH 0.53  0.08  0.00 (1.28)  0.00 (0.0194)  0.00  1.75 (0.66)  8.04 
LTSK 0.67  0.03  0.00  0.19  0.00 (0.0114)  0.00  2.77  0.00  17.26 
MTCN 2.20  0.11  0.05  0.20  2.27  0.0442 (2.74)  4.57 (3.80)  12.45 
NEWTL 0.37  0.00 (0.17)  0.13  0.40 (0.17) (0.50)  1.03 (0.72)  2.41 
NEWTZ 0.26  0.02 (0.21)  0.77  0.21 (0.16) (0.44)  0.59 (0.50)  3.17 
OXSQZ 0.49 (0.06)  0.00 (0.72)  0.00 (0.19)  0.00  0.93 (1.76)  4.65 

Bristol-Myers Squibb Competitive Analysis

The better you understand Bristol-Myers Squibb competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Bristol-Myers Squibb's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Bristol-Myers Squibb's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
BMYMPARGDBHFALCNFRLJSMLTSHLTSKMTCNNEWTLNEWTZ
 0.00 
 1,287 
Bristol-Myers
 1.20 
 21.93 
Argo Group
 0.67 
 24.00 
Brighthouse
 1.03 
 23.00 
Conifer
 3.35 
 18.74 
Navient
 1.59 
 16.00 
Ladenburg
 4.29 
 15.80 
Ladenburg
 1.81 
 64.05 
Arcelormittal
 0.36 
 24.91 
Newtek
 0.53 
 24.57 
Newtek
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Number of Shares Shorted
Current Ratio
Book Value Per Share
Net Asset
EBITDA
Cash and Equivalents
Cash Flow from Operations
Total Asset
Last Dividend Paid
Market Capitalization
Cash per Share
Beta
Net Income
Annual Yield
Total Debt
Debt to Equity
Revenue
Price to Earning
Gross Profit
Day Typical Price
Accumulation Distribution
Market Facilitation Index
Daily Balance Of Power
Rate Of Daily Change
Day Median Price
Price Action Indicator
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

Bristol-Myers Squibb Competition Performance Charts

Complement your Bristol-Myers Squibb position

In addition to having Bristol-Myers Squibb in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Semiconductor Thematic Idea Now

Semiconductor
Semiconductor Theme
Companies involved in production of semiconductor and semiconductor materials. The Semiconductor theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Semiconductor Theme or any other thematic opportunities.
View All  Next Launch
Continue to Bristol-Myers Squibb Correlation with its peers. You can also try Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Complementary Tools for analysis

When running Bristol-Myers Squibb price analysis, check to measure Bristol-Myers Squibb's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol-Myers Squibb is operating at the current time. Most of Bristol-Myers Squibb's value examination focuses on studying past and present price action to predict the probability of Bristol-Myers Squibb's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Bristol-Myers Squibb's price. Additionally, you may evaluate how the addition of Bristol-Myers Squibb to your portfolios can decrease your overall portfolio volatility.
CEO Directory
Screen CEOs from public companies around the world
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Please note, there is a significant difference between Bristol-Myers Squibb's value and its price as these two are different measures arrived at by different means. Investors typically determine Bristol-Myers Squibb value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bristol-Myers Squibb's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
BMYMP
 Stock
  

USD 1,287  0.00  0.00%   

Bristol-Myers Squibb competes with Argo Group, Brighthouse Financial, Conifer Holdings, Navient SR, and Ladenburg Thalmann; as well as few others. The company classifies itself under Healthcare sector and is part of Drug Manufacturers - Major industry. Analyzing Bristol-Myers Squibb competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Bristol-Myers Squibb to its intrinsic valuation because they are able to contrast its competitors on a relative basis.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Bristol-Myers Squibb competition on your existing holdings. Continue to Bristol-Myers Squibb Correlation with its peers.